Cooper Companies Crescita futura

Future criteri di controllo 3/6

Cooper Companies prevede che gli utili e i ricavi cresceranno rispettivamente di 23% e 7% all'anno. Si prevede che l'EPS crescerà di 24.1% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 10% in 3 anni.

Informazioni chiave

23.0%

Tasso di crescita degli utili

24.1%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	18.2%
Tasso di crescita dei ricavi	7.0%
Rendimento futuro del capitale proprio	10.0%
Copertura analitica	Good
Ultimo aggiornamento	14 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

BOVESPA:C1OO34 - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
10/31/2027	4,907	882	1,012	1,429	2
10/31/2026	4,473	778	703	1,051	13
10/31/2025	4,201	645	626	944	18
10/31/2024	3,903	447	541	816	17
7/31/2024	3,804	359	189	615	N/A
4/30/2024	3,732	340	122	550	N/A
1/31/2024	3,666	291	136	564	N/A
10/31/2023	3,593	294	215	608	N/A
7/31/2023	3,514	275	222	564	N/A
4/30/2023	3,427	288	387	685	N/A
1/31/2023	3,380	375	425	693	N/A
10/31/2022	3,308	386	450	692	N/A
7/31/2022	3,219	431	524	736	N/A
4/30/2022	3,139	948	487	696	N/A
1/31/2022	3,029	939	541	757	N/A
10/31/2021	2,923	2,945	524	739	N/A
7/31/2021	2,845	2,916	526	782	N/A
4/30/2021	2,660	2,355	414	671	N/A
1/31/2021	2,465	2,249	207	505	N/A
10/31/2020	2,431	238	176	487	N/A
7/31/2020	2,441	278	180	468	N/A
4/30/2020	2,542	343	234	552	N/A
1/31/2020	2,672	454	459	741	N/A
10/31/2019	2,653	467	421	713	N/A
7/31/2019	2,613	446	499	750	N/A
4/30/2019	2,594	427	561	788	N/A
1/31/2019	2,571	366	523	745	N/A
10/31/2018	2,533	140	-630	669	N/A
7/31/2018	2,443	128	-656	631	N/A
4/30/2018	2,339	131	N/A	551	N/A
1/31/2018	2,230	175	N/A	511	N/A
10/31/2017	2,139	373	N/A	594	N/A
7/31/2017	2,096	345	N/A	588	N/A
4/30/2017	2,055	329	N/A	562	N/A
1/31/2017	2,016	298	N/A	529	N/A
10/31/2016	1,967	274	N/A	510	N/A
7/31/2016	1,904	250	N/A	421	N/A
4/30/2016	1,851	207	N/A	388	N/A
1/31/2016	1,801	194	N/A	401	N/A
10/31/2015	1,797	204	N/A	391	N/A
7/31/2015	1,810	198	N/A	439	N/A
4/30/2015	1,780	241	N/A	450	N/A
1/31/2015	1,758	259	N/A	466	N/A
10/31/2014	1,718	270	N/A	455	N/A
7/31/2014	1,661	296	N/A	453	N/A
4/30/2014	1,640	297	N/A	448	N/A
1/31/2014	1,611	293	N/A	437	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di C1OO34 ( 23% all'anno) è superiore al tasso di risparmio ( 10.4% ).

Guadagni vs Mercato: Si prevede che gli utili di C1OO34 ( 23% all'anno) cresceranno più rapidamente del mercato BR ( 12.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di C1OO34 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di C1OO34 ( 7% all'anno) crescerà più lentamente rispetto al mercato BR ( 7.5% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di C1OO34 ( 7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di C1OO34 sarà basso tra 3 anni ( 10 %).

Cooper Companies Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024

The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. Provides Revenue Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. Updates Revenue Guidance for the Year 2023

The Cooper Companies, Inc. Provides Revenue Guidance for the Year 2023

Recent updates

The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024

The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024

The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024

The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. to Report Q2, 2024 Results on May 30, 2024

The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024

Girard Sharp LLP and Sauder Schelkopf LLC Files Lawsuit Against Coopersurgical, Inc. and the Cooper Companies, Inc

The Cooper Companies, Inc. Announces Resignation of Gary S. Petersmeyer from Board of Directors

Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc

Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc

The Cooper Companies, Inc. to Report Q1, 2024 Results on Feb 29, 2024

The Cooper Companies, Inc., Annual General Meeting, Mar 19, 2024

The Cooper Companies, Inc. Announces Retirement of Gary S. Petersmeyer as Director

The Cooper Companies, Inc. Provides Revenue Guidance for the Fiscal Year 2024

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors, Effective December 1, 2023

The Cooper Companies, Inc. to Report Q4, 2023 Results on Dec 07, 2023

The Cooper Companies, Inc. (NasdaqGS:COO) acquired Bakri Postpartum Balloon, Cervical Ripening Balloon, Doppler Blood Flow Monitor portfolio and gynecology surgery markets of Cook Medical Incorporated for $300 million.

The Cooper Companies, Inc. Updates Revenue Guidance for the Year 2023

The Cooper Companies, Inc. Provides Revenue Guidance for the Year 2023

The Cooper Companies, Inc. to Report Q1, 2023 Results on Mar 02, 2023

The Cooper Companies, Inc., Annual General Meeting, Mar 15, 2023

CooperCompanies Declares Cash Dividend, Payable on February 10, 2023

The Cooper Companies, Inc. Initiates Earnings Guidance for the Fiscal Year 2023

The Cooper Companies, Inc. to Report Q4, 2022 Results on Dec 08, 2022

the Cooper Companies, Inc. Appoints Cynthia Lucchese to Board of Directors

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full year 2022

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full Year Year 2022

CooperCompanies Appoints Nicholas Khadder as Its General Counsel and Corporate Secretary

The Cooper Companies, Inc. to Report Q3, 2022 Results on Aug 31, 2022

CooperCompanies Declares Semi-Annual Cash Dividend, Payable on August 11, 2022

The Cooper Companies, Inc. Provides Consolidated Earnings Guidance for the Third Quarter, Fourth Quarter and Full Year of Fiscal 2022

The Cooper Companies, Inc. Provides Revenue Earnings Guidance for the Fiscal Year 2022

The Cooper Companies, Inc. (NYSE:COO) signed a binding letter of intent to acquire Reproductive Health Business of Cook Medical for $880 million.

The Cooper Companies, Inc. to Report Q1, 2022 Results on Mar 03, 2022

The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2022

The Cooper Companies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

CooperCompanies Announces MiSight® Approval from Chinese National Medical Products Administration

The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index

the Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2021

The Cooper Companies, Inc. to Report Q1, 2021 Results on Mar 04, 2021

EssilorLuxottica Société anonyme (ENXTPA:EL) and The Cooper Companies, Inc. (NYSE:COO) agreed to acquire SightGlass Vision from The Cooper Companies, Inc. (NYSE:COO).

CooperCompanies Announces Board Changes

The Cooper Companies, Inc. Votes to Elect Teresa S. Madden to Fill the New Director Position, with Effect from December 1, 2020

The Cooper Companies, Inc. to Report Q4, 2020 Results on Dec 03, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita